Literature DB >> 3190190

Antibacterial properties of (2,3)-alpha- and (2,3)-beta-methylene analogs of penicillin G.

J G Christenson1, D L Pruess, M K Talbot, D D Keith.   

Abstract

The penam nucleus can assume two conformations; these are designated open and closed. The synthetic (2,3)-alpha- and (2,3)-beta-methylenepenams can be regarded as analogs of the open and closed conformations, respectively. It has been shown that the beta-methylenepenams are essentially inactive, suggesting that the closed conformation of penams is also inactive. In this study, we investigated a series of beta-lactams, all of which contained phenylacetamido side chains: penicillin G, the (2,3)-alpha- and (2,3)-beta-methylenepenams, and the 3-acetoxymethyl- and 3-methylcephalosporins. The alpha-methylenepenam and penicillin G were the most active compounds, while the beta-methylene isomer was only poorly active. Results with permeability mutants suggested that the alpha-methylene compound penetrated the outer membrane somewhat more readily than penicillin G did. The intrinsic potency of the alpha-methylenepenam appeared to be similar to that of penicillin G, on the basis of their affinities for penicillin-binding proteins and their abilities to inhibit peptidoglycan synthesis in ether-permeabilized Escherichia coli, while the beta-methylene analog had very poor intrinsic potency. The alpha-methylene analog was about 10-fold more efficient (Vmax/Km) than penicillin G as a substrate for the cephalosporinases from Enterobacter cloacae and Proteus vulgaris, but it was about 40-fold less efficient with penicillinase from Staphylococcus aureus. These results strongly support the hypothesis that the active conformation of penams is the open conformation and suggest that the position in space of the carboxyl group relative to the beta-lactam carbonyl is an important determinant of cephalosporinlike character, as distinct from penicillinlike character.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3190190      PMCID: PMC172334          DOI: 10.1128/AAC.32.7.1005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  24 in total

1.  Microbial uridine-5'-pyrophosphate N-acetylamino sugar compounds. I. Biology of the penicillin-induced accumulation.

Authors:  J L STROMINGER
Journal:  J Biol Chem       Date:  1957-01       Impact factor: 5.157

2.  Modification of peptidoglycan structure by penicillin action in cell walls of Proteus mirabilis.

Authors:  H H Martin; J Gmeiner
Journal:  Eur J Biochem       Date:  1979-04

3.  Peptidoglycan biosynthesis in a thermosensitive division mutant of Escherichia coli.

Authors:  D Mirelman; Y Yashouv-Gan; U Schwarz
Journal:  Biochemistry       Date:  1976-05-04       Impact factor: 3.162

4.  Bacterial resistance to beta-lactam antibiotics: crystal structure of beta-lactamase from Staphylococcus aureus PC1 at 2.5 A resolution.

Authors:  O Herzberg; J Moult
Journal:  Science       Date:  1987-05-08       Impact factor: 47.728

5.  Purification of beta-lactamases on QAE-sephadex.

Authors:  G W Ross; M G Boulton
Journal:  Biochim Biophys Acta       Date:  1973-06-06

6.  Lysis by beta-lactam antibiotics: structure-activity relationships in the cephalosporins.

Authors:  J M Hamilton-Miller
Journal:  J Appl Bacteriol       Date:  1976-12

7.  Properties of the penicillin-binding proteins of Escherichia coli K12,.

Authors:  B G Spratt
Journal:  Eur J Biochem       Date:  1977-01

8.  On the process of cellular division in Escherichia coli: a series of mutants of E. coli altered in the penicillin-binding proteins.

Authors:  H Suzuki; Y Nishimura; Y Hirota
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

9.  PURIFICATION AND PROPERTIES OF PENICILLINASES FROM TWO STRAINS OF BACILLUS LICHENIFORMIS: A CHEMICAL, PHYSICOCHEMICAL AND PHYSIOLOGICAL COMPARISON.

Authors:  M R POLLOCK
Journal:  Biochem J       Date:  1965-03       Impact factor: 3.857

10.  Affinity of carumonam for penicillin-binding proteins.

Authors:  R L Then; I Kohl
Journal:  Chemotherapy       Date:  1985       Impact factor: 2.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.